Commonwealth Equity Services’s Eledon Pharmaceuticals ELDN Stock Holding History

Commonwealth Equity Services’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.2K	Buy	+16,556	New	+$60.2K	﹤0.01%	4288

Other funds holding ELDN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

PAM

Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

PNFS

PW Nova Financial Services Newtown, Pennsylvania $466M AUM

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HFS

Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

RZH

Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return

Commonwealth Equity Services's ELDN Position: Q2 2026 in Review

Commonwealth Equity Services opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 16,556 shares worth $65.2K. The stake represents ﹤0.01% of the portfolio and ranks #4288 among its holdings.

38 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

Commonwealth Equity Services held 16,556 shares of Eledon Pharmaceuticals worth $65.2K as of Q2 2026.
Eledon Pharmaceuticals was a new Commonwealth Equity Services position in Q2 2026.
Eledon Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4288 holding.
38 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.